Skip to search formSkip to main contentSkip to account menu

erbulozole

Known as: Carbamic acid, (4-(((2-(1H-imidazol-1-ylmethyl)-2-(4-methoxyphenyl)-1,3-dioxolan-4-yl)methyl)thio)phenyl)-, ethyl ester, cis-(+-)-, Carbamic acid, (4-(((2-(1H-imidazol-1-ylmethyl)-2-(4-methoxyphenyl)-1,3-dioxolan-4-yl)methyl)thio)phenyl)-,ethyl ester, cis-(+-)- 
A water soluble congener of tubulozole and a tubulin binding agent with potential antimitotic and antineoplastic activities. Erbulozole targets and… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Dioxolanes
Microtubule Process

Narrower (1)

R 55,104

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Erbulozole (P.I.N.N.) (R 55 104) encapsulated into cyclodextrins: has it a combined antitumoral and radioprotective potential?
The clinically applicable formulation of the microtubule inhibitor erbulozole (R 55 104), dissolved into an aqueous hydroxypropyl… 
1991
1991
A Wernicke's encephalopathy‐like neurotoxicity induced by erbulozole
1991
1991
A Wernicke's encephalopathy-like neurotoxicity induced by erbulozole.
1989
1989
Influence of the synthetic microtubule inhibitor erbulozole (P.I.N.N.) (R 55 104), a new tubulozole congener, and gamma irradiation on murine tumors in vivo.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)